As of 3:59pm ET
| +0.50 / +3.63%|
The 9 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 17.00, with a high estimate of 24.00 and a low estimate of 10.00. The median estimate represents a +19.05% increase from the last price of 14.28.
The current consensus among 10 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.